Cold-Adapted Viral Attenuation (CAVA): Highly Temperature Sensitive Polioviruses as Novel Vaccine Strains for a Next Generation Inactivated Poliovirus Vaccine

• Barbara P. Sanders ,

  * E-mail: bsander2@its.jnj.com

  Affiliation Janssen Infectious Diseases and Vaccines, Pharmaceutical Companies of Johnson and Johnson, Leiden, the Netherlands

  ⨯
• Isabel de los Rios Oakes,

  Affiliation Janssen Infectious Diseases and Vaccines, Pharmaceutical Companies of Johnson and Johnson, Leiden, the Netherlands

  ⨯
• Vladimir van Hoek,

  Affiliation Janssen Infectious Diseases and Vaccines, Pharmaceutical Companies of Johnson and Johnson, Leiden, the Netherlands

  ⨯
• Viki Bockstal,

  Affiliation Janssen Infectious Diseases and Vaccines, Pharmaceutical Companies of Johnson and Johnson, Leiden, the Netherlands

  ⨯
• Tobias Kamphuis,

  Affiliation Janssen Infectious Diseases and Vaccines, Pharmaceutical Companies of Johnson and Johnson, Leiden, the Netherlands

  ⨯
• Taco G. Uil,

  Affiliation Janssen Infectious Diseases and Vaccines, Pharmaceutical Companies of Johnson and Johnson, Leiden, the Netherlands

  ⨯
• Yutong Song,

  Affiliation Department of Molecular Genetics and Microbiology, Stony Brook University, Stony Brook, New York, United States of America

  ⨯
• Gillian Cooper,

  Affiliation Division of Virology, National Institute for Biological Standards and Control, Potters Bar, United Kingdom

  ⨯
• Laura E. Crawt,

  Affiliation Division of Virology, National Institute for Biological Standards and Control, Potters Bar, United Kingdom

  ⨯
• Javier Martín,

  Affiliation Division of Virology, National Institute for Biological Standards and Control, Potters Bar, United Kingdom

  ⨯
• Roland Zahn,

  Affiliation Janssen Infectious Diseases and Vaccines, Pharmaceutical Companies of Johnson and Johnson, Leiden, the Netherlands

  ⨯
• John Lewis,

  Current Address: Aecsela Biologics, Little Compton, Rhode Island, United States of America

  Affiliation Janssen Infectious Diseases and Vaccines, Pharmaceutical Companies of Johnson and Johnson, Leiden, the Netherlands

  ⨯
• Eckard Wimmer,

  Affiliation Department of Molecular Genetics and Microbiology, Stony Brook University, Stony Brook, New York, United States of America

  ⨯
• Jerome H. H. V. Custers,

  Affiliation Janssen Infectious Diseases and Vaccines, Pharmaceutical Companies of Johnson and Johnson, Leiden, the Netherlands

  ⨯
• Hanneke Schuitemaker,

  Affiliation Janssen Infectious Diseases and Vaccines, Pharmaceutical Companies of Johnson and Johnson, Leiden, the Netherlands

  ⨯
• Jeronimo Cello,

  Affiliation Department of Molecular Genetics and Microbiology, Stony Brook University, Stony Brook, New York, United States of America

  ⨯
•  [ ... ],
• Diana Edo-Matas

  Affiliation Janssen Infectious Diseases and Vaccines, Pharmaceutical Companies of Johnson and Johnson, Leiden, the Netherlands

  ⨯
• [ view all ]
• [ view less ]